R1	Has_qualifier Arg1:T1 Arg2:T2	
*	OR T3 T4 T5 T6 T7 T8 T9
R2	Subsumes Arg1:T1 Arg2:T3	
R3	Has_qualifier Arg1:T12 Arg2:T13	
*	OR T15 T17 T16
R4	Subsumes Arg1:T12 Arg2:T15	
*	OR T19 T23 T21 T20 T22
R5	AND Arg1:T24 Arg2:T19	
R6	Has_temporal Arg1:T24 Arg2:T25	
R7	Has_temporal Arg1:T27 Arg2:T28	
R8	Has_index Arg1:T28 Arg2:T29	
R9	Has_index Arg1:T25 Arg2:T30	
R10	Has_index Arg1:T32 Arg2:T33	
R11	Has_temporal Arg1:T31 Arg2:T32	
*	OR T34 T35
R12	Has_qualifier Arg1:T36 Arg2:T37	
R13	Has_temporal Arg1:T36 Arg2:T34	
R14	Has_value Arg1:T40 Arg2:T41	
R15	AND Arg1:T39 Arg2:T40	
R16	Has_value Arg1:T45 Arg2:T46	
R17	AND Arg1:T44 Arg2:T45	
R18	Has_value Arg1:T51 Arg2:T52	
R19	AND Arg1:T49 Arg2:T51	
*	OR T39 T49 T42 T43 T44 T47
R20	Has_temporal Arg1:T55 Arg2:T54	
R21	AND Arg1:T55 Arg2:T56	
*	OR T57 T58
R22	AND Arg1:T57 Arg2:T59	
*	OR T61 T62
R23	Has_temporal Arg1:T65 Arg2:T66	
R24	Has_mood Arg1:T65 Arg2:T64	
*	OR T68 T67
R25	AND Arg1:T65 Arg2:T68	
R26	Has_value Arg1:T71 Arg2:T72	
*	OR T70 T71 T73
R27	Has_qualifier Arg1:T74 Arg2:T75	
R28	Has_index Arg1:T76 Arg2:T77	
R29	Has_temporal Arg1:T74 Arg2:T76	
*	OR T81 T83 T82
R30	Has_context Arg1:T83 Arg2:T84	
R31	Subsumes Arg1:T80 Arg2:T81	
T1	Condition 0 16	Organic diseases
T2	Qualifier 24 40	digestive system
T3	Condition 42 82	gastro-oesophageal reflux disease (GERD)
T4	Condition 84 89	ulcer
T5	Condition 91 111	chronic pancreatitis
T6	Condition 113 127	cholelithiasis
T7	Condition 129 148	fatty liver disease
T8	Condition 150 159	hepatitis
T9	Condition 161 179	cirrhosis of liver
T12	Condition 209 228	functional diseases
T13	Qualifier 236 252	digestive system
T15	Condition 262 287	dyskinesia of cystic duct
T16	Condition 262 275;291 302	dyskinesia of gallbladder
T17	Condition 304 328	irritable bowel syndrome
T19	Drug 355 377	proton pump inhibitors
T20	Drug 379 390	propulsives
T21	Drug 392 406	antispasmodics
T22	Drug 408 416	antacids
T23	Drug 421 441	bismuth preparations
T24	Observation 336 351	Discontinuation
T25	Temporal 442 481	less than 7 days prior to randomization
T27	Procedure 484 505	H. Pylori eradication
T28	Temporal 506 540	within 2 months before study entry
T29	Reference_point 529 540	study entry
T30	Reference_point 468 481	randomization
T31	Condition 543 563	Intestinal infection
T32	Temporal 564 598	within 2 months before study entry
T33	Reference_point 587 598	study entry
T34	Temporal 607 617	history of
T35	Mood 618 627	suspected
T36	Condition 628 646	malignant neoplasm
T37	Qualifier 650 663	various sites
T39	Condition 696 718	cardiovascular disease
T40	Measurement 737 763	New York Heart Association
T41	Value 687 695	class IV
T42	Condition 772 786	hypothyroidism
T43	Condition 788 805	diabetes mellitus
T44	Condition 807 829	chronic kidney disease
T45	Measurement 831 832	ะก
T46	Value 832 835	3-5
T47	Condition 841 857	disease of liver
T48	Condition 863 882	portal hypertension
T49	Condition 890 911	severe decompensation
T51	Measurement 913 929	Child-Pugh score
T52	Value 930 933	> 6
T54	Temporal 950 960	coexisting
T55	Condition 961 970	morbidity
T56	Non-query-able 978 1064	in the investigator's opinion, can prevent the patient from participating in the study
T57	Condition 1067 1074	Allergy
T58	Condition 1075 1086	intolerance
T59	Drug 1101 1148	components of medications used in the treatment
T61	Condition 1151 1160	Pregnancy
T62	Observation 1162 1176	breast-feeding
T63	Non-representable 1179 1351	Patients who, from investigator's point of view, will fail to comply with the observation requirements of the trial or with the dosing regimen of the investigational drugs.
T64	Mood 1353 1360	Planned
T65	Procedure 1361 1376	hospitalization
T66	Temporal 1377 1400	during the study period
T67	Procedure 1424 1444	treatment procedures
T68	Procedure 1410 1420;1434 1444	diagnostic procedures
T70	Condition 1447 1461	Drug addiction
T71	Measurement 1463 1474	alcohol use
T72	Value 1489 1518	over 2 units of alcohol a day
T73	Condition 1520 1535	mental diseases
T74	Drug 1548 1557	medicines
T75	Qualifier 1558 1614	listed in the section 'Prohibited concomitant treatment'
T76	Temporal 1619 1663	1 month prior to the enrollment in the trial
T77	Reference_point 1636 1663	the enrollment in the trial
T78	Competing_trial 1666 1753	Participation in other clinical trials within 3 months to the enrollment in this study.
T79	Non-representable 1755 2070	Patient is related to the research staff of the clinical investigative site who are directly involved in the trial or is the immediate family member of the investigator. The immediate family members include husband/wife, parents, children or brothers (or sisters), regardless of whether they are natural or adopted.
T80	Person 2080 2123	works for OOO "NPF "MATERIA MEDICA HOLDING"
T81	Person 2138 2156	company's employee
T82	Person 2158 2183	temporary contract worker
T83	Person 2187 2205	appointed official
T84	Observation 2206 2273	responsible for carrying out the research or their immediate family
